Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCP Infrastructure Investments Regulatory News (GCP)

Share Price Information for GCP Infrastructure Investments (GCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 76.60
Bid: 76.60
Ask: 76.60
Change: -0.60 (-0.78%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 77.20
GCP Live PriceLast checked at -
GCP Infrastructure Investments is an Investment Trust

To provide shareholders with regular, sustainable, long-term dividend income and to preserve the capital value of its investments over the long term by generating exposure to infrastructure debt and/or similar assets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Placing and Additional Listing

21 Nov 2014 07:00

RNS Number : 6298X
GCP Infrastructure Investments Ltd
21 November 2014
 



GCP Infrastructure Investments Limited

(the "Company")

 

 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS OR INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

This announcement does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or solicitation of any offer to buy or subscribe for, any shares in the Company or securities in any other entity, in any jurisdiction, including the United States, nor shall it, or any part of it, or the fact of its distribution, form the basis of, or be relied on in connection with, any contract or investment decision whatsoever, in any jurisdiction. This announcement does not constitute a recommendation regarding any securities.

 

Result of Placing and Additional Listing

21 November 2014

On 17 November 2014 the Company announced its intention to raise up to £70 million of additional capital by way of a placing of new ordinary shares of £0.01 each in the Capital of the Company ("Ordinary Shares") under the Placing Programme in accordance with the Prospectus published on 12 February 2014 (the "Placing"), to allow the Company to take advantage of a number of attractive immediate investment opportunities.

The Board is pleased to announce today that the Placing was significantly oversubscribed. Accordingly, the Company has raised £70 million of gross proceeds through the Placing of 62,639,821 new Ordinary Shares, subject to Admission. The placing price per new Ordinary Share was 111.75 pence.

Furthermore, the Company announces that pursuant to the scrip dividend alternative in lieu of cash for the dividend for the period from 1 July 2014 to 30 September 2014 announced on 16 October 2014, elections for a scrip dividend were received in respect of 10.5% of the Ordinary Shares in issue as at the record date of 24 October 2014.

Applications will be made in respect of the 62,639,821 new Ordinary Shares issued pursuant to the Placing and the 787,758 new Ordinary Shares issued pursuant to the scrip dividend alternative in lieu of cash to be admitted to the premium segment of the Official List and to trading on the London Stock Exchange's Main Market for listed securities ("Admission"). It is expected that Admission will become effective and dealings in the new Ordinary Shares will commence on 25 November 2014. When issued, the new Ordinary Shares will rank pari passu with the existing Ordinary Shares.

Following Admission, the Company's issued share capital will consist of 513,848,242 Ordinary Shares of £0.01 each. With effect from 25 November 2014, the total number of issued shares with voting rights will be 513,848,242.

The above figure of 513,848,242 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or of a change to their interest in the Company under the FCA's Disclosure and Transparency Rules. 

 

 

Contact details:

 

Gravis Capital Partners LLP

Stephen Ellis

+44 (0)20 7518 1495

Rollo Wright

+44 (0)20 7518 1493

Oriel Securities

Neil Winward

+44 (0)20 7710 7600

Mark Bloomfield

Tunga Chigovanyika

Cenkos Securities

Dion Di Miceli

Tom Scrivens

+44 (0)20 7397 1915

Buchanan

+44 (0)20 7466 5000

Charles Ryland

Sophie McNulty

 

About GCP Infrastructure Investments Limited

The Company is a closed-ended London Stock Exchange-listed investment company that seeks to generate returns from senior and subordinated infrastructure debt and related and/or similar assets. The Company is advised by Gravis Capital Partners LLP.

 

This announcement is not for distribution, directly or indirectly, in or into the United States of America (including its territories and possessions, any state of the United States of America and the District of Columbia) (the "United States"), Australia, Canada, Japan or South Africa or into any other jurisdiction where applicable laws prohibit its release, distribution or publication. This announcement does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase, any securities in the United States, Australia, Canada, Japan or South Africa or in any other jurisdiction where such offer or sale would be unlawful. The securities of the Company have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or the US Investment Company Act of 1940, as amended and may not be offered or sold directly or indirectly in or into the United States or to or for the account or benefit of any US Person (within the meaning of Regulation S under the Securities Act). The securities referred to herein have not been registered under the applicable securities laws of Australia, Canada, Japan or South Africa and, subject to certain exceptions, may not be offered or sold within Australia, Canada, Japan or South Africa or to any national, resident or citizen of Australia, Canada, Japan or South Africa.

 

This announcement has been issued by and is the sole responsibility of the Company. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by, Oriel Securities Limited, Cenkos Securities plc or by any of their respective affiliates or agents as to or in relation to the accuracy or completeness of this announcement or any other written or oral information made available to or publicly available to any interested party or their advisers and any liability therefore is expressly disclaimed.

 

Oriel Securities Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as joint broker and joint bookrunner to the Company and is acting for no-one else in connection with the Placing and the contents of this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Oriel Securities Limited nor for providing advice in connection with the Placing and the contents of this announcement or any other matter referred to herein.

 

Cenkos Securities plc, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as joint broker and joint book runner to the Company and is acting for no-one else in connection with the Placing and the contents of this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Cenkos Securities plc nor for providing advice in connection with the Placing and the contents of this announcement or any other matter referred to herein.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFMMZMRGVGDZM
Date   Source Headline
8th Jun 20219:47 amRNSAdditional Listing and Total Voting Rights
28th May 20219:23 amRNSAdditional Listing
13th May 20217:00 amRNSScrip Share Reference Price
30th Apr 20217:00 amRNSInvestor Report at 31 March 2021
21st Apr 202111:06 amRNSDividend Declaration & Scrip Dividend Alternative
19th Apr 20217:00 amRNSNet Asset Value(s)
31st Mar 20217:00 amRNSTotal Voting Rights
30th Mar 20217:00 amRNSRevolving Credit Facility
22nd Mar 20211:08 pmRNSNew Directorship Notification
12th Mar 20211:29 pmRNSHolding(s) in Company
9th Mar 20214:26 pmRNSDirector/PDMR Shareholding
9th Mar 20219:08 amRNSAdditional Listing and Total Voting Rights
26th Feb 20219:39 amRNSAdditional Listing
11th Feb 20217:00 amRNSScrip Share Reference Price
10th Feb 202112:50 pmRNSDirectorate Change
10th Feb 202112:49 pmRNSResult of AGM
27th Jan 20217:00 amRNSInvestor Report at 31 December 2020
22nd Jan 202111:54 amRNSDividend Declaration & Scrip Dividend Alternative
18th Jan 20217:00 amRNSNet Asset Value(s)
11th Jan 202110:31 amRNSUpdate research from QuotedData
8th Jan 20219:00 amRNSNotice of AGM Circular
31st Dec 20207:00 amRNSTotal Voting Rights
17th Dec 20207:00 amRNSAnnual report and financial statements
7th Dec 202012:37 pmRNSDirector/PDMR Shareholding
7th Dec 20209:13 amRNSAdditional Listing and Total Voting Rights
4th Dec 20207:00 amRNSInvestment Adviser strategic partnership
27th Nov 20207:00 amRNSAdditional Listing
12th Nov 20207:00 amRNSScrip Share Reference Price
30th Oct 20207:00 amRNSInvestor Report as at 30 September 2020
23rd Oct 202011:42 amRNSDividend Declaration & Scrip Dividend Alternative
23rd Oct 202010:41 amRNSDividend Declaration & Script Dividend Alternative
16th Oct 20207:00 amRNSNet Asset Value(s)
12th Oct 20207:00 amRNSGreen Economy Mark
3rd Sep 202012:50 pmRNSDirector/PDMR Shareholding
28th Aug 20209:56 amRNSAdditional Listing and Total Voting Rights
21st Aug 202012:54 pmRNSAdditional Listing
6th Aug 20207:00 amRNSScrip Share Reference Price
30th Jul 20207:00 amRNSInvestor Report as at 30 June 2020
28th Jul 20201:19 pmRNSNotification of Major Holdings
23rd Jul 202010:42 amRNSDividend Declaration & Scrip Dividend Alternative
15th Jul 20207:00 amRNSNet Asset Value(s)
30th Jun 20207:00 amRNSTotal Voting Rights
10th Jun 20205:35 pmRNSDirector/PDMR Shareholding
10th Jun 202012:04 pmRNSAdditional Listing and Total Voting Rights
3rd Jun 20207:00 amRNSAdditional Listing
1st Jun 20201:48 pmRNSUpdate research from QuotedData
29th May 20207:00 amRNSHalf-yearly Report and Financial Statements 2020
15th May 20207:00 amRNSScrip Share Reference Price
1st May 20207:00 amRNSInvestor Report as at 31 March 2020
24th Apr 202011:16 amRNSDividend Declaration & Scrip Dividend Alternative

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.